Date | Open(₹) | High(₹) | Low(₹) | Close(₹) | No. Of Trades(₹) | Total Turnover(₹) | Deliverable Quantity(₹) |
|---|---|---|---|---|---|---|---|
20-Jun-2025 | 518.6 | 524.85 | 515.2 | 520.15 | 6,635 | 4,15,75,976.75 | 30,213 |
23-Jun-2025 | 520 | 529.65 | 515 | 523.85 | 6,444 | 5,44,19,546.4 | 41,934 |
24-Jun-2025 | 525 | 536 | 522.1 | 530.85 | 5,937 | 5,96,28,797.55 | 47,631 |
25-Jun-2025 | 532 | 574.95 | 532 | 571.9 | 28,623 | 40,22,93,064.65 | 3,74,554 |
26-Jun-2025 | 576 | 580 | 553.65 | 573 | 21,380 | 24,46,14,106.9 | 1,55,613 |
27-Jun-2025 | 575 | 577 | 563.05 | 568.2 | 9,989 | 11,70,81,870.65 | 74,656 |
30-Jun-2025 | 561 | 584.95 | 547.7 | 582.65 | 22,737 | 33,01,67,578.15 | 2,43,434 |
01-Jul-2025 | 585 | 595 | 575.15 | 584.15 | 16,006 | 21,25,04,941.75 | 1,53,590 |
02-Jul-2025 | 584.15 | 588.95 | 573.8 | 581.15 | 11,156 | 11,83,93,418 | 84,930 |
03-Jul-2025 | 580 | 592.45 | 569 | 571.05 | 13,576 | 15,44,62,609.4 | 1,26,469 |
04-Jul-2025 | 575 | 578.2 | 563.25 | 566.8 | 6,807 | 6,75,78,322.45 | 49,405 |
07-Jul-2025 | 567 | 579.95 | 558.55 | 573.85 | 15,367 | 17,93,72,094.5 | 1,27,422 |
08-Jul-2025 | 573.85 | 613.95 | 570.1 | 590.85 | 17,806 | 24,60,93,137.2 | 1,85,060 |
09-Jul-2025 | 591 | 599 | 581 | 587.2 | 13,016 | 12,09,49,165.95 | 83,762 |
10-Jul-2025 | 584 | 593.45 | 575.65 | 588 | 7,277 | 9,84,72,710.35 | 79,294 |
11-Jul-2025 | 588 | 624.8 | 585.9 | 611.5 | 37,065 | 53,66,88,327.65 | 2,94,536 |
14-Jul-2025 | 611.5 | 619 | 602.2 | 612.45 | 13,776 | 16,80,20,810.75 | 1,01,536 |
15-Jul-2025 | 613 | 635 | 612 | 627.9 | 13,876 | 22,23,93,846.75 | 1,63,935 |
16-Jul-2025 | 630 | 631.3 | 615 | 616.95 | 8,706 | 9,67,06,791.2 | 77,268 |
17-Jul-2025 | 619 | 626 | 615.7 | 622.2 | 6,906 | 7,49,24,567.75 | 53,929 |
18-Jul-2025 | 623 | 626.8 | 615 | 624.35 | 8,519 | 10,34,05,359.65 | 87,550 |
Senores Pharmaceuticals intends to fund the acquisition through proceeds from its IPO, which raised ₹5.82 billion in December.
Senores Pharmaceuticals shares closed 6% below their listing price, although they are still up 43% from the IPO price.
IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000
IIFL Capital Services Support WhatsApp Number
+91 9892691696
Download The App Now
Follow us on
2025, IIFL Capital Services Ltd. All Rights Reserved
IIFL Capital Services Limited - Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248, DP SEBI Reg. No. IN-DP-185-2016
ARN NO : 47791 (AMFI Registered Mutual Fund Distributor)
This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.
